欧盟HMA药品数据库(European Union HMA Authorisation of Medicines DataBase)
MR编号
NL/H/0347/002
药品名称
Hospasol 167mmol/l
活性成分
Sodium hydrogen carbonate 0.0 [no unit]
剂型
Solution for infusion
上市许可持有人
GAMBRO Lundia AB Magistratsvägen 16 S-22010 Lund Sweden
参考成员国 - 产品名称
Netherlands (NL)
互认成员国 - 产品名称
France (FR)
Spain (ES)
Italy (IT)
Greece (GR)
许可日期
2002/10/23
最近更新日期
2018/01/10
药物ATC编码
B05ZB Hemofiltrates
申请类型
TypeLevel1:
Known Active Substance
TypeLevel2:
Additional Strength/Form
TypeLevel3:
Bibliographic Article 4.8 (a) (ii)
TypeLevel4:
Chemical Substance
TypeLevel5:
Prescription Only
附件文件下载
Final PL
|
common-pl-2016-11-hemosol
Date of last change:2017/09/27
Final PL
|
common-pl-2016-11-biphozyl
Date of last change:2017/09/27
Final PL
|
common-pl-2016-11-phoxilium
Date of last change:2017/09/27
Final PL
|
common-pl-2016-11-hospasol145
Date of last change:2017/09/27
Final PL
|
common-pl-2016-11-hospasol167
Date of last change:2017/09/27
Final PL
|
common-pl-2016-11-regiocit
Date of last change:2017/09/27
市场状态
Positive
©2006-2024
Drugfuture
->
European Union HMA Authorisation of Medicines DataBase